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Abstract
Postmortem studies have revealed a downregulation of the transcription factor Pax5 in
GABAergic neurons in bipolar disorder, a neurodevelopmental disorder, raising the question
whether Pax5 in GABAergic neurons has a role in normal brain development. In a genetic
approach to study functions of Pax5 in GABAergic neurons, Pax5 was specifically deleted in
GABAergic neurons from Pax5 floxed mice using a novel Gad1-Cre transgenic mouse line
expressing Cre recombinase in Gad1-positive, i.e. GABAergic neurons. Surprisingly, these mice
developed a marked enlargement of the lateral ventricles at approximately seven weeks of age,
which was lethal within 1–2 weeks of its appearance. This hydrocephalus phenotype was observed
in mice homozygous or heterozygous for the Pax5 conditional knockout, with a gene dosage-
dependent penetrance. By QTL (quantitative trait loci) mapping, a 3.5 Mb segment on mouse
chromosome 4 flanked by markers D4Mit237 and D4Mit214 containing approximately 92 genes
including Pax5 has previously been linked to differences in lateral ventricular size. Our findings
are consistent with Pax5 being a relevant gene underlying this QTL phenotype and demonstrate
that Pax5 in GABAergic neurons is essential for normal ventricular development.
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INTRODUCTION
Pax5 is a paired box gene, which functions as a transcription factor in canonical Wnt
signaling and determines cellular fate in the cerebral cortex and hippocampus (Machon et
al., 2007). In the mid gestation stage, a dynamic gradient of Wnt signaling controls neural
tube patterning (Ciani and Salinas, 2005), which is controlled by an organizing center
located at the midbrain/hindbrain boundary where Pax5 is highly expressed (Bouchard et al.,
2000). Glutamic acid decarboxylase 67 (GAD67), encoded by the Gad1 gene, is responsible
for synthesis of GABA from glutamate and is widely distributed in the brain (Tamamaki et
al., 2003). It is expressed in postmitotic and proliferating cells, suggesting that using this
gene promoter to drive Cre will allow recombination of floxed genes at these stages to study
fundamental cellular activities such as differentiation and migration during developmental
stages (Ma et al., 1992; Tashiro et al., 2007). A Pax5 global knockout is postnatally lethal
(Urbanek et al., 1994). To explore the role of Pax5 in inhibitory neurons on brain
development and function, we have generated GAD67-specific conditional Pax5-deficient
mice (Gad1-Pax5KO).
RESULTS
Generation and analysis of Gad1-Cre mice
To achieve expression of the Cre recombinase in GAD67-expressing GABAergic neurons,
we generated a Gad1-Cre transgenic mouse using chromosomal Gad1 sequences from a
BAC clone (Fig. 1A). Gad1-Cre transgenic mice did not show gross abnormalities (Fig. 1B)
and were indistinguishable from their wild type (WT) littermates in open-field tests (Fig.
S1).
The recombination profile of Gad1-Cre transgenic mice was assessed using the reporter
lines Rosa26-EYFP (Srinivas et al., 2001) and Z/EG (Novak et al., 2000) in which EYFP
(Enhanced Yellow Fluorescent Protein) or EGFP (Enhanced Green Fluorescent Protein) is
expressed upon Cre-mediated recombination of a loxP-flanked STOP-cassette. We observed
EYFP-immunoreactive (-IR) cells in various brain areas that contain GABAergic neurons
including the brainstem, cerebellum, inferior and superior colliculus, hypothalamus and
dentate gyrus of hippocampus and neocortex (mainly layers IV–VI) (Fig. 1B). However, in
some brain areas which are rich in GABAergic neurons (Fig. S2) only few cells showed
recombination, e.g. in the striatum (Fig. 1B) and the olfactory bulb (data not shown). Gad1-
Cre-mediated recombination was already present at E12.5 (Fig. 2B) and in P7 pups its
pattern was similar to that seen in adult animals (Fig. 2A).
To examine the specificity of recombination events in Gad1-Cre mice co-immunostaining
studies were performed in the lower layers (layers IV–VI) of the somatosensory cortex. In
the mice examined, 100% and 81.8% of EYFP-IR cells were colabeled with GABA,
indicating that the recombination is specific for GABAergic cells (Fig. 3A, Table S1, Fig.
S4). Conversely, 42.1% and 40.9% of GABA-positive cells were positive for EYFP,
indicating that less than half of the GABAergic cells can be targeted by the Gad1-Cre
recombinase. Some EYFP-IR cells were labeled using an antibody against GAD67 (Fig. 3B).
However, the GAD67 staining is punctated and it is not easy to distinguish signal from
background and cell bodies from neurites. We think that this could be the reason why not all
EYFP-IR cells are recognized as GAD67-positive. There are multiple populations of
GABAergic interneurons, which are defined by the presence of marker proteins. To assess
which interneuronal population expresses the Gad1-Cre transgene, double-labeling
experiments were performed, which revealed that 25.6%–39.8% of the EYFP-positive cells
were positive for parvalbumin, and 23.0%–30.9% of parvalbumin-positive cells were
colabeled with EYFP (Fig. 3C, TableS1, Fig. S5A). No EYFP-positive cells were co-labeled
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with calretinin or neuropeptide Y (TableS1, Fig. S5B). None of EYFP-positive cells was
colocalized with the excitatory neurotransmitter glutamate (Fig. 3D, Table S1). Furthermore,
Gad1-Cre-mediated recombination does not occur in dopaminergic neurons as shown by the
absence of reporter signal from tyrosine hydroxylase (TH)-positive neurons (Fig. 3E).
Recombination was absent in astrocytes and oligodendrocytes (Fig. 3F,G). Collectively, this
initial analysis shows that the Gad1-Cre transgene is expressed in parvalbumin-positive
interneurons and as yet unidentified interneuron classes, excluding the calretinin or
neuropeptide Y-expressing subtypes.
Gad1-Pax5KO mice develop hydrocephalus in a gene dosage-dependent manner
The Gad1-Cre line was crossed with Pax5-floxed mice (Horcher et al., 2001) to generate
Gad1-Pax5KO mice with a conditional deletion of Pax5 in GAD67-expressing neurons (Fig.
4A). About 47% of homozygous mutant mice (Gad1-Cre, Pax5f/f) and 19% of heterozygous
mutant mice (Gad1-Cre, Pax5f/+) developed a dome-shaped skull around postnatal day 50
(Fig. 4B), indicating that the development of hydrocephalus is dependent on the Pax5 gene
dosage (p=0.0021, Spearman’s rank correlation; Fig. 4C and D). Gad1-Pax5KO mice died
approximately one to two weeks after the appearance of macroscopic changes (Fig. 4D), and
displayed lethargy and emaciation. Both homozygous and heterozygous mutants developing
a dome-shaped head had a life expectancy of 58 days (Fig. 4D) whereas animals not
developing this phenotype by P60 were able to survive for at least 12 months and were
fertile. Abnormalities were not observed in littermates with control genotypes (Gad1-Cre;
Pax5f/+; Pax5f/f).
Gad1-Pax5KO mice have enlarged lateral ventricles
The ventriculomegaly of Gad1-Pax5KO was prominent in the lateral ventricles (Fig. 5, Fig.
S6). In the most severe cases, the medial structures between lateral ventricles were deformed
and compressed as represented by vertically relocated hippocampi (Fig. 6B, arrow 1). The
cerebral cortex surrounding the lateral ventricles was also markedly thinner (Fig. 6B, arrow
2). The ventricular dilation may be caused by obstruction of interventricular connections,
increased production of cerebrospinal fluid by ependymal cells of the choroid plexus or
decreased resorption by arachnoid villi. Since our present analysis provided no evidence for
the enlargement of other ventricles, the extensive enlargement of the lateral ventricles
indicates an obstruction of interventricular connections, while other possibilities cannot be
excluded. The potential contribution of other mechanisms, e.g. that Gad1-Cre-induced
recombination in the choroid plexus (Fig. S3) may have affected ependymal cell function,
remain to be elucidated.
Gad1-Pax5KO mice show increased locomotion and anxiogenic-like behavior in the open
field test
Locomotor activity of Gad1-Pax5KO mice with dome-shaped heads was assessed in a novel
open field. All four measures taken, i.e. distance traveled, speed, time spent in center and
number of entries into center showed significant differences in genotype, (F1,77=20.94,
p=0.0026; F1,77=18.94, p=0.0033; F1,77=9.1, p=0.0196; F1,77=9.3, p=0.0187, respectively,
by two-way repeated measures ANOVA). Bonferroni posthoc analysis confirmed these
differences (Fig. 7A). Since the mutants appeared to be lethargic in their home cages, the
increased locomotion is likely induced by the novel environment. The observation that
mutant mice spent less time in the center and entered the center less frequently (Fig. 7B, C)
is potentially indicating an anxiogenic-like behavior.
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DISCUSSION
The major phenotype of these mice, i.e. enlargement of the lateral ventricles has been found
to be associated with neurodevelopmental disorders such as schizophrenia (Meduri et al.,
2010; Rosa et al., 2010) and bipolar disorder (Kempton et al., 2008) [not in the first episode
(Rosa et al., 2010), only when psychosis was present (Edmiston et al., 2011)]. Thus, reduced
Pax5 expression in GABAergic neurons in patients with bipolar disorder (Benes et al., 2007)
might contribute to changes of ventricular size observed in these patients.
Pax5 is strongly expressed in the mid-hindbrain boundary (MHB) at embryonic stages while
in adults the expression level is low and expression appears to be widespread (Allen
Developing Mouse Brain Atlas, http://developingmouse.brain-map.org). It is tempting to
speculate that Pax5-deficiency in the MHB of the embryo may be responsible for the
hydrocephalus phenotype in Gad1-Pax5KO mice. However, the time window for the
appearance of hydrocephalus is quite narrow, potentially suggesting a role of the Pax5-
deficit in the adult animals in the pathogenesis of hydrocephalus in the Gad1-Pax5KO mice.
To address this question, temporal control of Pax5 expression in GAD67-positive neurons
would be required. Our finding that GABAergic neurons can play a role in determining
ventricular size is consistent with the observation of a linear correlation between degree of
ventricular enlargement and reduction of GAD-immunoreactive neurons in a kaolin-induced
hydrocephalus model in rats (Tashiro et al., 1997).
It is interesting to note that one functional copy of Pax5 is not sufficient to maintain a
normal development, as a sizable percentage of Gad1-Pax5+/− mice develop hydrocephalus
(Fig. 4C). While global Pax5+/− have not been examined in this study, such mice have been
generated in other contexts (e.g. as breeders to generate Pax5−/− mice), and development of
an obvious hydrocephalus like the one observed in this study has not been noticed, which
does not exclude the possibility that a more subtle ventricular enlargement may be present.
This raises the question why heterozygous loss of Pax5 in GABAergic neurons leads to
hydrocephalus, while global heterozygous loss of Pax5 is so far not known to do so. While
we do not know the answer to this question, one speculative possibility is that in global
Pax5+/− mice loss of Pax5 in other cell types helps to compensate for loss of Pax5 in
GABAergic neurons. Another noteworthy aspect is that not all Gad1-Pax5−/− mice develop
hydrocephalus (Fig. 4C), indicating the presence of modifier genes. This is in line with
previous observations that several genes have an influence on ventricle size in the mouse
(Zygourakis and Rosen, 2003).
Gad1 is thought to be expressed exclusively in neurons, and our analysis supports the notion
that the Gad1-Cre transgene is expressed specifically in GABAergic neurons. However, we
cannot completely rule out the possibility that Gad1-Cre is also expressed in non-neuronal
tissues and that Gad1-Cre-mediated recombination in non-neuronal cells might lead to
hydrocephalus. Gad1 knockout mice (and also Gabrb3 knockout mice which lack the
GABAA receptor β3 subunit or mice lacking the vesicular inhibitory amino acid transporter
Viaat) have been found to have a cleft palate phenotype (Asada et al., 1997; Condie et al.,
1997; Homanics et al., 1997; Wojcik et al., 2006). The developmental mechanism of cleft
palate in these mice are unknown, but it is not unreasonable to assume that non-neuronal
cells are involved in the development of cleft palate. However, it has been shown recently
that CNS-specific inactivation of Gad1 was sufficient to disrupt palate development (Oh et
al, 2010), suggesting that the primary defect is in the CNS. We assume that the same is true
for the hydrocephalus phenotype in the Gad1-Pax5−/− mice.
Pax2 and Pax5 arose by gene duplication and have maintained equivalent biochemical
functions (Bouchard et al., 2000). It has been suggested that there is functional substitution
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between Pax2 and Pax5 in brain regionalization (Schwarz et al., 1997). Pax2 expression in
the MHB positively regulates Pax5 expression through a Pax-binding site of a minimal
MHB-specific enhancer in the 5′-flanking region of Pax5 (Pfeffer et al., 2000).
Combinatorial interactions between the transcription factors Pax2, En1, Grg4, Otx2, Gbx2,
and the signaling molecule Wnt1 control the expression of FGF8, which is required to
maintain mid-hindbrain identity by supporting development of multiple neurons (Ciani and
Salinas, 2005; Ye et al., 2001). FGF8, Wnt, En1, En2, Pax2 and Pax5 depend on each other
for stable expression; if one is missing, the expression of the remaining genes is
extinguished over time, and these genes can induce and maintain each other’s expression at
ectopic locations (Funahashi et al., 1999; Wurst and Bally-Cuif, 2001; Ye et al., 2001).
These interactions establish a positive regulatory loop, which governs brain development as
an organizer located at the MHB. The direct interactions between Pax2 and the MHB-
specific enhancer in the 5′-flanking region of Pax5 mentioned above are directly involved in
this feedback loop (Pfeffer et al., 2000). Hydrocephalus has also been observed in other
mutants of genes in this regulatory network, e.g. Otx2+/− mice (Makiyama et al., 1997),
Wnt1 null mutants, transgenic mice expressing En1 ectopically under the control of the
Wnt1 enhancer, and Wnt1sw/sw (swaying) point mutants (Louvi and Wassef, 2000; Rowitch
et al., 1999; Thomas and Capecchi, 1990), demonstrating the essential role of the MHB
region for ventricular development. All previous loss-of-function studies have been
performed with global mutants, so that no conclusion could be drawn as to the relevant
neuronal cell types required for normal ventricular development. Our data clearly implicate
that GABAergic neurons, and in particular, Pax5-dependent functions in these neurons, play
a pivotal role in this process. The closely related gene, Pax6, is expressed in the
subcomissural organ (SCO) from which neuroepithelial cells originate, and mice lacking
Pax6 fails to develop the SCO (Estivill-Torrus et al., 2001). In the H-Tx rats which develop
congenital hydrocephalus, Pax6 is downregulated (Miller et al., 2006). Thus, Pax6 could
play a role in the development of hydrocephalus. Recently, it has also been reported that
deregulation of the p57-E2F1-p53 axis in the SCO and Pax2-positive interneurons results in
non-obstructive hydrocephalus and cerebellar malformation in mice (Matsumoto et al.,
2011).
QTL mapping revealed a 3.5 Mb locus on chromosome 4 containing 92 genes including
Pax5, which interacts with another as yet uncharacterized locus on chromosome 7 to
modulate ventricle size of the mouse brain (Zygourakis and Rosen, 2003). Our data suggests
that Pax5 is likely a major gene at this locus responsible for modulating ventricle size.
METHODS
Generation of Gad1-Cre mouse line
The plasmid pIZKeoX1 containing the Cre-IRES-lacZ construct (Fig. 1) was generated in E.
coli. The Neo cassette with flanking frt sequences was inserted downstream of the Cre-
IRES-lacZ in reversed orientation. Homologous arms of 50bp were added for subsequent
specific recombination into the first coding ATG of the Gad1 gene in the BAC clone,
RPCI23-118N13 (BACPAC resources, Children’s Hospital, Oakland, USA) by ET
recombination (Muyrers et al., 2004). Specifically, the cassettes inserted into the BAC clone
consists of a hybrid intron (HI) followed by the Cre-recombinase encoding gene, an internal
ribosomal entry site (IRES), the beta-galactosidase gene (lacZ) for identification of
transgene expression by X-gal staining, and a neomycin/kanamycin cassette (neo) for
selection of recombined BAC clones in E. coli. The Neo cassette was removed by Flp-
mediated recombination at the frt sites after the selection. The consequent transgenic
construct was validated also by DNA sequencing at the borders of insertion sites using
primer1 5′-ACGGCCGGAGTGGACACCTGTGGAGAG-3′ for the boundary between the
first coding ATG of Gad1 and Cre, and primer 2 5′-AGATCAGCAGCCTCTGTTCCACAT
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3′ at the boundary between frt and Gad1. BAC DNA was prepared using a CsCl gradient
centrifugation-based method or a QIAGEN kit for large constructs. Circular BAC DNA was
injected at 1–2ng/μl into pronuclei of oocytes (CBA/C57 hybrid). Offspring of founder mice
was screened for transgene expression by X-gal staining, showing that the LacZ-cassette is
functional in the cerebellum and superior colliculus (regions with many Gad1-Cre and LacZ
expressing cells). However, LacZ expression was relatively weak presumably due to low
efficiency of the IRES site. Cre recombinase function was tested in crosses with reporter
mice which express EYFP or EGFP after Cre-mediated deletion of a STOP-cassette
(Rosa26-EYFP reporter line, Srinivas et al. 2001; Z/EG reporter line, Novak et al. 2000).
Generation of Gad1-Pax5KO mice
Pax5 floxed mice had been backcrossed to C57BL/6 at least 8 generations, Gad1-Cre mice
for at least 4 generations. After these backcrossings, Gad1-Cre mice were crossed with
floxed Pax5 mice.
Experiments involving mice at the Mailman Research Center of the McLean Hospital were
approved by the Institutional Animal Care and Use Committee of McLean Hospital
(protocols #07-1/2-1 and #08-1/2-2 to UR), and all animal procedures at the European
Biology Molecular Laboratory (Mouse Biology Unit) conformed to National and
International laws and policies (EEC Council Directive 86/609, OJ L 358, 1, December 12,
1987; NIH Guide for the Care and Use of Laboratory Animals, NIH Publication No. 85-23,
1985 revised in 1995), personal project number: 7.1; at the Centre for Neuroregeneration,
conformed to UK legislation (Scientific procedures) ACT 1986 and the University of
Edinburgh ethical review committee policy, personal project license: 60/4049. Mouse
reagents will be made available to the research community.
Histology and Immunostainings
Adult mice and pups were anesthetized by intraperitoneal injection of 3% avertin in PBS,
and perfused with PBS, followed by 4% PFA in PB buffer (pH7.4) for fixation. Embryos
were dissected out of the uterus of the mother (euthanized by cervical dislocation).
Dissected brains and embryos were postfixed in 4% PFA at 4 °C overnight, then rinsed
twice with cold PBS and stored in cold 30% sucrose in Tris-azide buffer for 2–3 days at 4°C
followed by cryopreservation in embedding medium (OCT Sakura TissueTek). Cryosections
(30μm) were obtained using a Leica cryostat CM3050S and for DAB stainings were
incubated in 0.1M PB buffer (pH7.4), quenched with 2% H2O2, washed in TBS, blocked in
10% serum in histo solution (0.3% carrageenan, 0.5% triton X-100, in TBS), incubated with
the primary antibody in 1% serum in histo solution at 4°C for 24–72 hrs, washed in wash
solution (1% serum in 0.5% triton X-100 in TBS), incubated with the secondary antibody in
1% serum in histo solution at 4°C overnight, rinsed in wash solution, incubated in vectastain
ABC solution for 1hr, washed in TBS and TB, and incubated in 0.5mg/ml DAB and 0.03%
H2O2, followed by cold TB washes, drying and mounting in DEPEC-Eukitt. For
immunofluorescent stainings after the primary antibody incubation, sections were washed in
TBS and incubated in secondary antibody in TBS at room temperature for 2hrs, washed in
TBS, stained with DAPI, dried and mounted in vectashield mounting medium. Stained
sections were analyzed using a dissecting microscope (Leica MZ12 and Zeiss Schott
KL1500 light source and Leica FireCam 1.2.0 imaging software) or a Leica fluorescent
microscope (Leica DMR and camera DC500 and imaging software IM500 or a Leica
confocal microscope LASAF TCS SP5). For histological analyses Gad1-Cre, and Pax5
mutant brains were fixed as described above except that animals were anesthetized using
Isoflurane and sliced using a coronal brain dice at AP: Bregma +0.38 and −4.16,
approximately for macro photography shown in Fig 5 and Fig S6. Series of 25μm coronal
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sections were prepared after cryoprotection procedure at 100μm interval, and were subjected
to hematoxylin/eosin staining.
Antibodies
EGFP (for DAB:1:2000, ab290 Abcam; for IF:1:3000 ab10980 Abcam), GABA (1:1000,
A2052 Sigma), glutamate (1:1000, G9282 Sigma), GAD67 (for DAB: 1:, for IF: 1:1000,
MAB5406 Chemicon), parvalbumin (1:1000, P3088 Sigma), calretinin (1:2000, #7699/4
Swant), NPY (1:8000, ab10980 Abcam), TH (1:200, #Mab318 Chemicon), GFAP (1:1000,
#sc9065 Santa Cruz), CNPase (1:100, #Mab326 Chemicon), biotinylated anti-chicken, -
mouse, -rabbit (1:200, Vector Labs), Alexa488-anti-chicken (1:1000, Molecular Probes),
Alexa555-anti-mouse, -rabbit (1:1000, Molecular Probes)
Behavioral Analysis
All behavioral studies were performed on male mice, littermates being housed together.
Mice were moved to the behavioral facility at least a week before starting the tests in order
to allow for habituation to the new environment.
Novelty-Induced Locomotor Activity in Gad1-Cre Mice
After habituation to the test room four mice at a time were placed into four different open
field arenas (50 × 50 × 28 cm) at light conditions of 100 lux in the arena and video tracked
for 30min. The time spent and distance traveled at the border and at the center of the arena
were recorded using VideoMot2, version 5.62 (TSE). A 34 cm × 34 cm square inside the
open field was arbitrarily defined as center of the field.
Novelty-Induced Locomotor Activity in Gad1-Cre Pax5 Mutants
Mice were placed in 42 × 42 × 31 cm plexiglas chambers lit at 160 lux. Mice were
videorecorded for 60 minutes. Five minutes time bins were applied to process activity
measurements by the aid of computer software EthoVision XT (Noldus Information
Technology). A 20 cm × 20 cm square inside the open field was arbitrarily defined as center
of the field.
Statistics
Data in Fig. 4D, “Percent appearance of the symptom” was analyzed by Spearman’s rank
correlation for number of deleted Pax5 alleles by appearance of the symptom. Data in Figs.
7 and S1 are expressed as mean ± SEM. Data in Fig S1A and B were analyzed by two-way
ANOVA (genotype x area). Data in Fig S1C was analyzed by unpaired 2-sample t-test. Data
in Fig. 7A,B were analyzed by two-way repeated-measures ANOVA (genotype x time) and
the mutant group and control group were compared by two-sided Student’s t-test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Generation and Characterization of Gad1-Cre Transgenic Mice
(A) Schematic diagram of the Cre-IRES-LacZ transgene that was inserted at the first coding
ATG of the Gad1 gene on BAC RPCI23-118N13. The Neo cassette was removed by Flp-
mediated recombination at the frt sites after selection. (B) Gad1-Cre-mediated
recombination visualized using anti-EG(Y)FP antibody in a 4.5 month-old Gad1-Cre,
Rosa26yfp/yfp mouse. Upper panels: Representative images of a sagittal (left), and a coronal
section (right). Lower panels: magnification of the areas indicated with solid and dotted
lines in the upper left panel. Lower left panel: layers I–VI of somatosensory cortex. Lower
right panel: anterior part of the hippocampus. bs, brainstem; cb, cerebellum; co, colliculi; cx,
neocortex; dg, dentate gyrus; hi, hippocampus; hy, hypothalamus; st, striatum; th, thalamus;
bactP, bacterial promoter; frt, Flp recombinase target site; H, hybrid intron; HA,
homologous arm; IRES, internal ribosomal entry site; LacZ, beta-galactosidase encoding
gene; Neo, neomycin resistance gene; PA, polyadenylation signal; SVe, SV40 enhancer.
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Figure 2. Gad1-Cre-Mediated Recombination During Development
(A) Colorimetric immunostaining using an antibody against EG(Y)FP on a sagittal brain
section of a P7 Gad1-Cre, Rosa26yfp/+ mouse. (B–C) Colorimetric immunostaining using an
antibody against EGFP on a sagittal (B) and coronal (C) section of an E12.5 Gad1-Cre, Z/
EG embryo. (D–E) Direct detection of EGFP in Gad1-Cre, Z/EG at E12.5. (D) Magnified
image corresponding to the inset in (B). (E) Magnified image corresponding to the inset in
(C). bs, brainstem; cb, cerebellum; co, colliculi; cx, neocortex; dh, dorsal horn; fb, forebrain;
hi, hippocampus; md, medulla; mid, midbrain; pv, prevertebrae; spc, spinal cord; st,
striatum; th, thalamus; vh, ventral horn; 4th vent, 4th ventricle.
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Figure 3. Specific recombination mediated by Gad1-Cre in GABAergic neurons but not
glutamatergic neurons or glial cells. (A–E)
Double immunostaining of a 4.5 months old Gad1-Cre, Rosa26yfp/yfp reporter mouse. The
recombination marker, EYFP (green) and (A) GABA, (B) GAD67, (C) parvalbumin, and (D)
glutamate (red) were superimposed in the layers IV–VI of somatosensory cortex. (E) The
recombination marker, EYFP (green) and tyrosine hydroxylase (TH) (red) were
superimposed in the substantia nigra. (F–G) Double immunostaining of a 3 months old
Gad1-Cre, Rosa26yfp/+ reporter mouse. The recombination marker, EYFP (green) and (F)
glial fibrillary protein (GFAP) (red) in the layers IV–VI of somatosensory cortex and (G) 2′,
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3′-cyclic nucleotide 3′ phosphodiesterase (CNPase) (red) in the superior colliculus were
superimposed. Scale bar: 100μm.
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Figure 4. Generation of Gad1-Pax5KO and Developmental Phenotype
(A) Schematic diagram of generation of the Gad1-Pax5KO mice. (B) Morphological
appearance of a homozygous Gad1-Cre, Pax5f/f mouse (“KO”) characterized by dome-
shaped head, kyphosis and emaciation, compared to a Pax5f/f (“Control”) mouse (postnatal
days 35, littermates). (C) Schematic diagram of gene dosage-dependent partial penetrance of
the lateral ventricle dilation of the Gad1-Pax5KO (D) Life span and prevalence of
hydrocephalus in Gad1-Cre-Pax5-deficient mice.
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Figure 5. Lateral Ventricle-Specific Dilation in Gad1-Pax5KO mice
Brain preparations from three mutant (“KO”) mice with examples of either no macroscopic
abnormalities (“mild”, and “severe”, P46) or dome-shaped head (“terminal”, P41), and
“Control” (P60) mice demonstrating dilation of the lateral ventricles. For further examples,
see Fig. S6.
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Figure 6. Hematoxylin-eosin staining of coronal serial sections of Gad1-Pax5KO mice
Example images of (A) “Control” at positions from Bregma: AP-0.34, -1.46, -1.82, -2.46
and -6.36 approximately and (B) Sections from equivalent positions from “KO” with dome-
shaped head. Postnatal days 60. Arrow 1: hippocampus, arrow 2: cortex.
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Figure 7. Novelty-Induced Locomotor Activity in Gad1-Pax5KO Mice (A–C)
Open-field test in mutant mice with dome-shaped heads (n=2 and 1 for Gad1-Cre, Pax5f/f
and Gad1-Cre, Pax5f/+, respectively) and control mice (n=6, Pax5f/f) at postnatal days 40–
42. The data are expressed as mean ± SEM. (A) Locomotor activity in the entire arena. (B)
Time spent in the center and number of entries into the center. (C) Representative paths of
total 60 minutes. *p<0.05, **p<0.01 and ***p<0.001, respectively (Bonferroni post hoc
analysis).
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